1. Home
  2. TRDA vs BYND Comparison

TRDA vs BYND Comparison

Compare TRDA & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$11.67

Market Cap

404.4M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$0.94

Market Cap

446.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
BYND
Founded
2016
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
404.4M
446.9M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
TRDA
BYND
Price
$11.67
$0.94
Analyst Decision
Strong Buy
Sell
Analyst Count
1
7
Target Price
$20.00
$1.70
AVG Volume (30 Days)
200.0K
54.8M
Earning Date
02-26-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,520,000.00
$290,565,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$0.50
52 Week High
$14.27
$7.69

Technical Indicators

Market Signals
Indicator
TRDA
BYND
Relative Strength Index (RSI) 64.79 44.53
Support Level $10.34 $0.90
Resistance Level $11.49 $1.11
Average True Range (ATR) 0.72 0.09
MACD 0.08 0.01
Stochastic Oscillator 83.51 35.41

Price Performance

Historical Comparison
TRDA
BYND

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: